These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
255 related items for PubMed ID: 17443200
21. Cardiovascular instability after patent ductus arteriosus ligation in preterm infants: the role of hydrocortisone. Satpute MD, Donohue PK, Vricella L, Aucott SW. J Perinatol; 2012 Sep; 32(9):685-9. PubMed ID: 22094490 [Abstract] [Full Text] [Related]
22. Early systemic hypotension and vasopressor support in low birth weight infants: impact on neurodevelopment. Pellicer A, Bravo MC, Madero R, Salas S, Quero J, Cabañas F. Pediatrics; 2009 May; 123(5):1369-76. PubMed ID: 19403504 [Abstract] [Full Text] [Related]
23. Continuous indomethacin infusion may be less effective than bolus infusions for ductal closure in very low birth weight infants. de Vries NK, Jagroep FK, Jaarsma AS, Elzenga NJ, Bos AF. Am J Perinatol; 2005 Feb; 22(2):71-5. PubMed ID: 15731984 [Abstract] [Full Text] [Related]
24. Short-term outcome of PDA ligation in the preterm infants at King Chulalongkorn Memorial Hospital, Thailand. Benjacholmas V, Namchaisiri J, Lertsarpcharoen P, Punnahitananda S, Thaithumyanon P. J Med Assoc Thai; 2009 Jul; 92(7):909-13. PubMed ID: 19626809 [Abstract] [Full Text] [Related]
25. Comparison of oral ibuprofen and indomethacin therapy for patent ductus arteriosus in preterm infants. Fakhraee SH, Badiee Z, Mojtahedzadeh S, Kazemian M, Kelishadi R. Zhongguo Dang Dai Er Ke Za Zhi; 2007 Oct; 9(5):399-403. PubMed ID: 17937843 [Abstract] [Full Text] [Related]
26. Indomethacin responsiveness of patent ductus arteriosus and renal abnormalities in preterm infants treated with indomethacin. Itabashi K, Ohno T, Nishida H. J Pediatr; 2003 Aug; 143(2):203-7. PubMed ID: 12970633 [Abstract] [Full Text] [Related]
27. Postoperative cardiorespiratory instability following ligation of the preterm ductus arteriosus is related to early need for intervention. Teixeira LS, Shivananda SP, Stephens D, Van Arsdell G, McNamara PJ. J Perinatol; 2008 Dec; 28(12):803-10. PubMed ID: 18615091 [Abstract] [Full Text] [Related]
28. Predictors of ductal closure and intestinal complications in very low birth weight infants treated with indomethacin. Madan J, Fiascone J, Balasubramanian V, Griffith J, Hagadorn JI. Neonatology; 2008 Dec; 94(1):45-51. PubMed ID: 18196930 [Abstract] [Full Text] [Related]
29. Early hemodynamic consequences of patent ductus arteriosus in preterm infants with intrauterine growth restriction. Rakza T, Magnenant E, Klosowski S, Tourneux P, Bachiri A, Storme L. J Pediatr; 2007 Dec; 151(6):624-8. PubMed ID: 18035142 [Abstract] [Full Text] [Related]
30. Indomethacin prophylaxis or expectant treatment of patent ductus arteriosus in extremely low birth weight infants? Cordero L, Nankervis CA, Delooze D, Giannone PJ. J Perinatol; 2007 Mar; 27(3):158-63. PubMed ID: 17251986 [Abstract] [Full Text] [Related]
31. Effect of antihypotensive treatment on cerebral oxygenation of preterm infants without PDA. Bonestroo HJ, Lemmers PM, Baerts W, van Bel F. Pediatrics; 2011 Dec; 128(6):e1502-10. PubMed ID: 22065269 [Abstract] [Full Text] [Related]
32. Effects of low oxygen saturation limits on the ductus arteriosus in extremely low birth weight infants. Noori S, Patel D, Friedlich P, Siassi B, Seri I, Ramanathan R. J Perinatol; 2009 Aug; 29(8):553-7. PubMed ID: 19461594 [Abstract] [Full Text] [Related]
33. Effects of Prophylactic Indomethacin on Vasopressor-Dependent Hypotension in Extremely Preterm Infants. Liebowitz M, Koo J, Wickremasinghe A, Allen IE, Clyman RI. J Pediatr; 2017 Mar; 182():21-27.e2. PubMed ID: 27915200 [Abstract] [Full Text] [Related]
34. Renal impairment associated with indomethacin treatment for patent ductus arteriosus in extremely preterm neonates--is postnatal age at start of treatment important? Srinivasjois RM, Nathan EA, Doherty DA, Patole SK. J Matern Fetal Neonatal Med; 2006 Dec; 19(12):793-9. PubMed ID: 17190690 [Abstract] [Full Text] [Related]
35. Cardiovascular effects of low-dose dexamethasone in very low birth weight neonates with refractory hypotension. Noori S, Siassi B, Durand M, Acherman R, Sardesai S, Ramanathan R. Biol Neonate; 2006 Dec; 89(2):82-7. PubMed ID: 16158007 [Abstract] [Full Text] [Related]
36. Failure of ductus arteriosus closure is associated with increased mortality in preterm infants. Noori S, McCoy M, Friedlich P, Bright B, Gottipati V, Seri I, Sekar K. Pediatrics; 2009 Jan; 123(1):e138-44. PubMed ID: 19117835 [Abstract] [Full Text] [Related]
37. Short- and long-term consequences of hypotension in ELBW infants. Fanaroff AA, Fanaroff JM. Semin Perinatol; 2006 Jun; 30(3):151-5. PubMed ID: 16813974 [Abstract] [Full Text] [Related]
38. Disseminated candidal infections and intravenous hydrocortisone in preterm infants. Botas CM, Kurlat I, Young SM, Sola A. Pediatrics; 1995 Jun; 95(6):883-7. PubMed ID: 7761215 [Abstract] [Full Text] [Related]
39. The effects of indomethacin tocolysis on the postnatal response of the ductus arteriosus to indomethacin in extremely low birth weight infants. Cordero L, Nankervis CA, Gardner D, Giannone PJ. J Perinatol; 2007 Jan; 27(1):22-7. PubMed ID: 17053778 [Abstract] [Full Text] [Related]
40. Morphine, hypotension, and adverse outcomes among preterm neonates: who's to blame? Secondary results from the NEOPAIN trial. Hall RW, Kronsberg SS, Barton BA, Kaiser JR, Anand KJ, NEOPAIN Trial Investigators Group. Pediatrics; 2005 May; 115(5):1351-9. PubMed ID: 15867047 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]